| Synonyms: | |
| Status: | Approved (1995) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N02AX02 |
| UNII: | 39J1LGJ30J |
| InChI Key | TVYLLZQTGLZFBW-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H25NO2 |
| Molecular Weight | 263.38 |
| AlogP | 2.63 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 32.7 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Property Name | Value | Unit | Method |
|---|---|---|---|
| log P (octanol-water) | 3.010 | - | EST |
| Atmospheric OH Rate Constant | 1.47E-10 | cm3/molecule-sec | EST |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Opioid receptor
|
1300 | 7600-7600 | - | 1600-2000 | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 1493-4300 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 52500 | - | - | 60 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Abdominal Pain | 3 | D015746 | ClinicalTrials |
| Opioid-Related Disorders | 3 | D009293 | ClinicalTrials |
| Fibromyalgia | 3 | D005356 | ClinicalTrials |
| Diabetic Neuropathies | 3 | D003929 | ClinicalTrials |
| Chronic Pain | 3 | D059350 | ClinicalTrials |
| Osteoarthritis, Knee | 3 | D020370 | ClinicalTrials |
| Low Back Pain | 3 | D017116 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Rotator Cuff Injuries | 2 | D000070636 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Osteoarthritis | 2 | D010003 | ClinicalTrials |
| Hip Fractures | 2 | D006620 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Wounds and Injuries | 2 | D014947 | ClinicalTrials |
| Neuralgia | 2 | D009437 | ClinicalTrials |
| Substance Withdrawal Syndrome | 2 | D013375 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 27203-92-5 |
| ChEBI | 75722 |
| ChEMBL | CHEMBL1237044 |
| EPA CompTox | DTXSID00860388 |
| FDA SRS | 39J1LGJ30J |
| Guide to Pharmacology | 8286 |
| SureChEMBL | SCHEMBL57496 |